Roche acquires Ventana Medical Systems (2008)
Roche paid $3.4 billion for Ventana, the leading maker of automated tissue-staining systems for pathology labs. The acquisition came after a six-month hostile bid that Ventana initially resisted.
Ventana became the core of Roche's Tissue Diagnostics business, giving Roche an installed base in pathology labs worldwide.
Roche became the only major pharma company with a captive pathology hardware franchise, enabling the companion-diagnostic strategy that now extends into AI software.
Ventana was the hardware layer; PathAI is the software layer. Roche is methodically assembling vertical control of cancer pathology workflows—stains, slides, digital images, AI analysis, and the drugs the analysis recommends.
